Artigo · Revista · 2019

Inhibition of JAK-STAT and NF-κB signalling systems could be a novel therapeutic target against insulin resistance and type 2 diabetes

Hauwa'u Y. Bako, Mohammed Auwal Ibrahim, Muhammad Sani Isah, Sani Ibrahim

Life Sciences

• Acesso fechado
• 10% mais citados do mundo

Ir para a editora10.1016/j.lfs.2019.117045